Pacific Biosciences Of California (PACB) Non-Current Assets (2010 - 2026)

Pacific Biosciences Of California has reported Non-Current Assets for 17 years, with the latest figure at $413.2 million in Q2 2026.

• On a quarterly basis, Non-Current Assets changed 0.28% year-over-year to $413.2 million in Q2 2026; TTM through Jun 2026 was $1.6 billion, a 33.13% decrease from a year earlier, with the FY2025 full-year figure at $409.0 million, down 46.52% from the prior year.
• Non-Current Assets was $413.2 million for Q2 2026 at Pacific Biosciences Of California, roughly flat from $412.8 million in the prior quarter.
• The five-year high for Non-Current Assets was $1.0 billion in Q3 2023, with the low at $408.9 million in Q3 2025.
• Average Non-Current Assets over 5 years is $747.6 million, with a median of $893.2 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets jumped 1499.18% in 2022, then sank 58.12% in 2025.
• Over 5 years, Non-Current Assets stood at $915.0 million in 2022, then rose by 9.72% to $1.0 billion in 2023, then dropped by 23.83% to $764.8 million in 2024, then plunged by 46.52% to $409.0 million in 2025, then rose by 1.02% to $413.2 million in 2026.
• The last three Non-Current Assets figures came in at $413.2 million (Q2 2026), $412.8 million (Q1 2026), and $409.0 million (Q4 2025), per Business Quant data.